Anti-Estrogens
Toremfine
Product Details Dragon Pharma
Active Substance Toremifene Citrate Selective estrogen receptor modulator (SERM)
Strength 20 mg/tablet
Package 100 tablets 2,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 5 days Slow elimination partly due to enterohepatic circulation
Drug Class SERM Selective estrogen receptor modulator
Mechanism Estrogen receptor modulation Acts as an estrogen agonist or antagonist depending on target tissue
Primary Concerns QT prolongation and hepatic effects Cardiac and liver-related monitoring may be required
$150.00
Shipping Location :
International
U.S. Domestic
Related Offers
Lab Tested
Domestic & International
Buy 5+ for $61.38 and save $23.10
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Anastrozole Nonsteroidal aromatase inhibitor
Strength 1 mg/tablet
Package 100 tablets 100 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 50 hours About 2 days
Mechanism Aromatase inhibition Reduces conversion of androgens to estrogens
Aromatization Not applicable Inhibits aromatase rather than undergoing aromatization
Primary Concerns Low estrogen, bone density and cholesterol changes Estrogen suppression requires appropriate medical monitoring
$66.00
Lab Tested
Domestic & International
Buy 5+ for $61.38 and save $23.10
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance
Clomiphene Citrate
Selective estrogen receptor modulator (SERM)
Strength
50 mg/tablet
Package
100 tablets
5,000 mg total labeled content
Form
Oral tablets
Pharmacokinetics
Prolonged and isomer-dependent
Zuclomiphene may persist substantially longer than enclomiphene
Drug Class
SERM
Selective estrogen receptor modulator
Mechanism
Estrogen receptor modulation
Influences hypothalamic-pituitary gonadotropin signaling
Primary Concerns
Visual disturbances and hepatic effects
Requires appropriate medical supervision
$66.00
Lab Tested
Domestic & International
Buy 5+ for $107.88 and save $40.60
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Exemestane Steroidal aromatase inhibitor
Strength 25 mg/tablet
Package 100 tablets 2,500 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 24 hours
Mechanism Irreversible aromatase inhibition Steroidal aromatase inactivator
Aromatization Not applicable Inhibits aromatase rather than undergoing aromatization
Primary Concerns Low estrogen, bone density and lipid changes Estrogen suppression requires appropriate medical monitoring
$116.00
Domestic & International
Buy 5+ for $61.38 and save $23.10
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Letrozole Nonsteroidal aromatase inhibitor
Strength 2.5 mg/tablet
Package 100 tablets 250 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 2 days
Drug Class Aromatase inhibitor Nonsteroidal estrogen-synthesis inhibitor
Mechanism Aromatase inhibition Reduces conversion of androgens to estrogens
Primary Concerns Low estrogen, bone density and cholesterol changes Estrogen suppression requires appropriate medical monitoring
$66.00
Lab Tested
Domestic & International
Buy 5+ for $46.50 and save $17.50
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Tamoxifen Citrate Selective estrogen receptor modulator (SERM)
Strength 20 mg/tablet
Package 100 tablets 2,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 5–7 days Major metabolites may persist considerably longer
Drug Class SERM Selective estrogen receptor modulator
Mechanism Estrogen receptor modulation Competes with estrogen for receptor binding in target tissues
Primary Concerns Thromboembolic and estrogen-related effects Associated with increased risk of DVT and pulmonary embolism
$50.00
Lab Tested
Domestic & International
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Isotretinoin Systemic retinoid
Strength 20 mg/capsule
Package 100 capsules 2,000 mg total labeled content
Form Oral capsules
Estimated Half-Life Approximately 18–21 hours Mean elimination half-life varies by formulation and study
Primary Use Severe recalcitrant nodular acne
Aromatization Not applicable Retinoid, not an androgenic steroid
Primary Concerns Embryo-fetal toxicity, liver and lipid abnormalities Pregnancy is contraindicated
$72.00
Lab Tested
Shipped USA Domestic
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Raloxifene Hydrochloride Selective estrogen receptor modulator (SERM)
Strength 60 mg/tablet
Package 100 tablets 6,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 27.7 hours Prolonged by enterohepatic cycling
Drug Class SERM Selective estrogen receptor modulator
Mechanism Estrogen receptor modulation Acts as an estrogen agonist or antagonist depending on target tissue
Primary Concerns Venous thromboembolism Associated with increased risk of deep vein thrombosis and pulmonary embolism
$171.00
Lab Tested
Shipped USA Domestic
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Minoxidil Direct-acting peripheral vasodilator
Strength 10 mg/tablet
Package 100 tablets 1,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 4 hours Hemodynamic effects persist considerably longer
Drug Class Peripheral vasodilator Antihypertensive agent
Mechanism Direct arteriolar vasodilation Reduces peripheral vascular resistance
Primary Concerns Fluid retention, tachycardia and pericardial effusion Oral minoxidil requires appropriate cardiovascular monitoring
$125.00